Sign in
4

Changes in Ownership

Solid Biosciences Inc. Filed Acc 0001193125-25-308118

Chief Operating Officer sold 4,932 shares at $5.11 ($25,203)

  • Chief Operating Officer acquired 13,051 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Howton David T Chief Operating Officer 2025-12-02 Option exercise 10b5-1 +13,051 37,840 D
Howton David T Chief Operating Officer 2025-12-03 Sale 10b5-1 −4,932 $5.11 $25,203 32,908 D
Derivatives
Howton David T Chief Operating Officer 2025-12-02 Option exercise · Restricted Stock Units 10b5-1 −13,051 13,052 D
Open-market sales · 4,932 sh · avg $5.11 · $25,203
Loading xslF345X05/ownership.xml…